Cryosite was first established in 2001 and is 100% Australian owned. Cryosite Limited, ABN 86 090 919 476, is an independent public listed company registered on the main board of the Australian Stock Exchange with the code CTE.
Our leaders are committed to upholding our high level of professionalism – our Management team ensures our operations are gold standard and the Cryosite board of directors provides corporate governance oversight.
Cryosite also operates a clinical trials logistic business and a biorepository sample storage facility. We are committed to supporting health care and medical research in Australia.